Telephone results study – Dr Sian Taylor-Phillips, Associate Professor of Screening and Test Evaluation, Warwick Medical School
Sian Taylor-Phillips is Professor of Population Health at the University of Warwick. She specialises in evaluating and synthesising evidence about screening programmes for national decision-makers. She has been involved in primary research in breast cancer screening for 15 years.
Genetics App SGH – Dr Katie Snape, Consultant Cancer Geneticist, St George’s Hospital
This talk aims to:
• Define the utility of family history assessment in stratifying women into mammographic screening pathways.
• Compare and contrast the resource implications of full family history assessment in all women either with breast cancer or with a family history of breast cancer using manual versus digital approaches.
• Analyse the impact of the Family History Questionnaire Service (FHQS) app in streamlining family history data collection and assessment in a cancer genetics servcie serving a population of 3.5 million.
Dr Katie Snape is a consultant cancer geneticist who jointly leads the Cancer Genetics Service of the Southwest Thames Regional Genetics Service, St George’s University Hospitals NHS Foundation Trust. Dr Snape is motivated to translate the seismic revolution in genomic technologies into tangible improvements in patient care delivered by evidence based, sustainable clinical pathways. This work has involved developing the infrastructure for incorporating somatic and germline whole genome sequence data into the routine care pathways of cancer patients, and transformational digital innovation projects such as the Family History Questionnaire Service (FHQS). FHQS is a cancer family history app which enables patients to input their personal and family history of cancer information online. The app presents family history data to trained clinicians for risk assessment, and integrates directly into the patients electronic genetics record for clinical accountability, thus improving access of cancer patients and their relatives to genetic testing, and Screening, Prevention and Early Detection (SPED) services. Dr Snape also specialises in clinical genomics education. She is currently a co-investigator on the CRUK project CanGene-CanVar, which aims to develop a national educational infrastructure for the translation of genomic data into clinical care pathways for individuals with inherited cancer risk.
How do women experience a false positive test result from breast screening? A systematic review and thematic synthesis – Miss Hannah Long, PhD student, University of Manchester
This talk aims to:
• Explain what is currently known (and not known) about how false positive test results impact women.
• Give examples of the cognitive and emotional impact of being recalled to screening assessment on women, e.g. specific beliefs or worries.
• Describe women’s preferences for in-person communication of false positive test results.
• Identify one practice or research implication of the study findings.
Hannah Long is a PhD student in Health Psychology within the NIHR Manchester Biomedical Research Centre at the University of Manchester. Her PhD aims to understand the psychological impact of false positive test results in the NHS Breast Screening Programme, mainly in terms of cancer worry and screening uptake. Hannah’s PhD research also explores the communication of false positive test results and screening as an opportunity for assisting health behaviour change. Before starting her PhD, Hannah was employed as a Research Assistant at the Manchester Centre for Health Psychology and completed an MSc in Health Psychology and a BSc (Hons) in Psychology. Her research interests include the role of psychology and behavioural science in cancer prevention and early detection, health decision-making, qualitative research methods and evidence synthesis.
